Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- Soricimed Biopharma Inc
- Target Recruit Count
- 23
- Registration Number
- NCT01578564
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇨🇦Juravinski Cancer Center, Hamilton, Ontario, Canada
🇨🇦London Health Sciences Centre, London, Ontario, Canada
News
No news found